Intensive Care News and Research

RSS

Africa has the highest death rates among critically ill COVID-19 patients, shows study

Africa has the highest death rates in the world among critically ill COVID-19 patients, with limited intensive care resources a major factor, a study says.

29 May 2021

Study links barotrauma to COVID-19 in younger patients

To better understand the possible relationship between severe infection and poor in-hospital outcomes, researchers from the Internal Medicine, and the Pulmonary Critical Care Medicine, Rutgers University, Newark, USA, presented a case series linking barotrauma to COVID-19 in younger patients.

28 May 2021

Negative peripartum experiences with the onset of COVID-19: Belgian midwifery case study

It is well known that the onset of the coronavirus disease 2019 (COVID-19) pandemic disrupted most non-essential healthcare services, including antenatal care. A new study from Belgium presents a snapshot of the experiences of midwives in that country during the months of May and June 2020.

27 May 2021

New study launched to understand COVID impact on mental health in parents and babies

The COVID-19 pandemic turned the lives of many all over the world upside down. Nowhere has this been more obvious than the interactions between parents and children, beginning during pregnancy, over the past year of the pandemic. A new study from Oxford and Cambridge in the UK will explore the reality of changes in this area, and how they have impacted early human development.

26 May 2021

Men with low testosterone levels are more susceptible to severe COVID-19

Throughout the pandemic, doctors have seen evidence that men with COVID-19 fare worse, on average, than women with the infection.

25 May 2021

Researchers develop a novel probiotic formulation with high anti-SARS-CoV-2 potency

A team of international scientists recently conducted a randomized clinical trial to assess the safety and efficacy profiles of a novel probiotic formulation in symptomatic coronavirus disease 2019 (COVID-19) patients. The findings indicate that the probiotic formulation is highly effective in reducing symptom severity in COVID-19 patients without causing any adverse events.

25 May 2021

Are COVID-19 medications safe in pregnancy?

Most medications being tested today in clinical trials for the treatment of coronavirus disease 2019 (COVID-19) have been repurposed from other indications. These are typically not tested in pregnant women. A new study, published in the journal PLOS ONE, summarizes what is known about the safety of these drugs in this group.

24 May 2021

Which biomarkers can help predict adverse outcomes in COVID-19?

A team of researchers has conducted a systematic review to identify laboratory factors that can predict the risk of severe and critical COVID-19 as well as associated mortality rates. The team – from institutions in India and the USA – recently published their findings in the Journal of Clinical Medicine Research.

24 May 2021

Risk factors for rare COVID-19 complications in children (MIS-C)

While the earlier waves of COVID-19 relatively spared children, some of the affected children have developed a systemic inflammatory condition, with occasionally fatal outcomes. Called multisystem inflammatory syndrome in children (MIS-C), its pathogenesis and risk factors are the subject of a new study on the medRxiv* preprint server.

21 May 2021

Tokyo sees rapid rise of SARS-CoV-2 R.1 lineage

A new research paper posted to the preprint server medRxiv* reports the rise of a new lineage in Tokyo, Japan, bearing a combination of two biologically important mutations.

20 May 2021

The effects of SARS-CoV-2 vaccination on pregnancy and birth

The severe impact of this infection has given rise to a study by Theiler et al. (2021), which investigated the effects of SARS-CoV-2 vaccination in pregnancy in order to examine the protection it could provide to combat the infection.

19 May 2021

Robust T cell and humoral immune response to SARS-CoV-2 in patients with immunodeficiency

A study of immune-deficient adults and children has shown that patients who fail to respond positively to infections and vaccinations have robust humoral immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structural proteins.

18 May 2021

Moderate therapeutic hypothermia does not improve neurological outcomes after cardiac arrest

In patients receiving therapeutic hypothermia after suffering out-of-hospital cardiac arrest, those who were cooled below 31 degrees Celsius (about 88 degrees Fahrenheit) for 24 hours showed no difference in terms of death or poor neurological outcomes at six months compared with patients receiving guideline-recommended cooling of 34 C (about 93 F).

18 May 2021

COVID-19 mRNA vaccines safe and effective for pregnant and breastfeeding women

The current coronavirus disease 2019 (COVID-19) pandemic has brought untold devastation in its wake, with its rapid and asymptomatic spread to hundreds of millions of people the world over. Vaccines have been hailed as the way out of this situation, and a dozen or so are being rolled out in many different countries.

18 May 2021

STEMI patients with multi-vessel disease have no benefit from FFR-guided PCI

In patients who had a coronary stent inserted after experiencing the most severe type of heart attack, the use of a technique that measures blood flow and pressure through a partially blocked artery to determine if a second stenting procedure is needed did not improve outcomes and was more costly than using angiography, or a heart X-ray, alone to guide the procedure, according to research presented at the American College of Cardiology’s 70th Annual Scientific Session.

17 May 2021

$Researchers compare characteristics and outcomes of hip fracture patients during pre- and post-COVID-19 outbreak$

Researchers compare characteristics and outcomes of hip fracture patients during pre- and post-COVID-19 outbreak

The COVID-19 pandemic has been shown to have caused a significant strain on the healthcare system and resources in the United States.

17 May 2021

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

Researchers in the UK have presented a multi-omics integrated blood atlas that delineates the host immune response in patients with coronavirus disease 2019 (COVID-19) of varying severity, providing a unique reference resource for the interpretation of datasets generated from interventional trials.

13 May 2021

Intensive Care News and Research

Africa has the highest death rates among critically ill COVID-19 patients, shows study

Study links barotrauma to COVID-19 in younger patients

Negative peripartum experiences with the onset of COVID-19: Belgian midwifery case study

New study launched to understand COVID impact on mental health in parents and babies

Men with low testosterone levels are more susceptible to severe COVID-19

Researchers develop a novel probiotic formulation with high anti-SARS-CoV-2 potency

Are COVID-19 medications safe in pregnancy?

Which biomarkers can help predict adverse outcomes in COVID-19?

Risk factors for rare COVID-19 complications in children (MIS-C)

Tokyo sees rapid rise of SARS-CoV-2 R.1 lineage

The effects of SARS-CoV-2 vaccination on pregnancy and birth

Robust T cell and humoral immune response to SARS-CoV-2 in patients with immunodeficiency

Moderate therapeutic hypothermia does not improve neurological outcomes after cardiac arrest

COVID-19 mRNA vaccines safe and effective for pregnant and breastfeeding women

STEMI patients with multi-vessel disease have no benefit from FFR-guided PCI

Researchers compare characteristics and outcomes of hip fracture patients during pre- and post-COVID-19 outbreak

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

New, non-invasive method measures brain blood flow with light

Sepsis can cause alterations in the functioning of defense cells that lead to death

Sepsis can cause alterations in the functioning of defense cells that lead to death

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News